Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes
  di: Setor K. Kunutsor, et al.
  Pubblicazione: (2024)
• Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
  di: Setor K. Kunutsor, et al.
  Pubblicazione: (2024)
• Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
  di: Jiaqiang Zhang, et al.
  Pubblicazione: (2025)
• Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials
  di: Magdaline Zawadka, et al.
  Pubblicazione: (2026)
• Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes
  di: Ying He, et al.
  Pubblicazione: (2024)